在患有高风险复发/耐药古典霍奇金淋巴瘤的儿童中,固定低剂量尼沃卢马布和本达穆斯丁的组合治疗
Shyam Srinivasan1,2, Aditya Narayan1,2, Chetan Dhamne1,2
1Department of Paediatric Oncology, Tata Memorial Hospital/ACTREC, Mumbai, India.
British journal of haematology
|May 21, 2025
概括
尼沃卢马布和本达穆斯丁的组合在治疗儿科高风险古典霍奇金淋巴瘤方面表现出高效. 这种治疗实现了88%的完全响应率,为复发或耐药性疾病的年轻患者提供了显著的希望.
科学领域:
- 儿科瘤学 儿科瘤学
- 血液学 血液学 血液学
- 免疫治疗是一种免疫疗法.
背景情况:
- 儿童的古典霍奇金淋巴瘤 (cHL) 存在重大治疗挑战,特别是在复发或折射性病例中.
- 对于患有复发性/耐药性cHL的儿科患者,有效的治疗选择有限,需要新的治疗策略.
研究的目的:
- 在患有高风险复发/耐药古典霍奇金淋巴瘤的儿科患者中评估固定低剂量尼沃卢马布和本达穆斯丁组合的疗效和安全性.
主要方法:
- 进行了一项回顾性研究,涉及18名被诊断患有高风险复发/耐药古典霍奇金淋巴瘤的儿科患者.
- 患者接受了尼沃卢马布和本达穆斯丁的固定低剂量组合治疗方案.
主要成果:
- 组合疗法显示出了惊人的88%的完全响应率.
- 一年无进展生存率 (PFS) 为88.2%,一年整体生存率 (OS) 为94.4%.
结论:
- 尼沃卢马布和本达穆斯丁的固定低剂量组合是一种高度有效的治疗方法,用于患有复发性/耐药性古典霍奇金淋巴瘤的儿科患者.
- 这种疗法提供了有希望的长期生存结果,因此需要在前性研究中进一步调查.
更多相关视频
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.1K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.2K
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Bone Marrow Sampling and Transplants
268
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
268
Tumor Immunotherapy
454
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
454
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
